Module

Hepatitis B: Prevention of Cirrhosis and Hepatocellular Carcinoma

Source: Diagnosis, Treatment, and Chronic Care Options for Hepatitis B

Hepatitis B: Prevention of Cirrhosis and Hepatocellular Carcinoma


CME Program Director: Patrick J. Lynch, MD

Program Director: Eugene R. Schiff, MD, MACP, FRCP, MACG

Faculty:

Adrian M. Di Bisceglie, MD, FACP
  • Adrian M. Di Bisceglie, MD, FACP

CME CREDIT INFORMATION

Release Date: 07/18/05

Expiration Date: 07/17/06


Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.1 Nursing CE credits

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: Please log in to view status

Begin the Module

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the diagnostic approaches to hepatitis B virus infection.

  • Discuss the natural history of chronic hepatitis B, including the progression of liver disease to cirrhosis, end-stage disease, and hepatocellular carcinoma.

  • Review the currently recommended approaches for the treatment of chronic hepatitis.


Content includes:

  • Natural History of Hepatitis B
  • Assessment of HBV Disease
  • Effect of Antiviral Therapy on Progression to Cirrhosis
  • Effect of Antiviral Therapy on Patients Who Have Cirrhosis
  • Hepatocellular Carcinoma
  • Epidemiology of HCC
  • Pathogenesis of HBV-Related HCC
  • Clinical Features of HCC
  • Natural History of HCC
  • Treatment of Chronic Hepatitis B and Impact on HCC
  • Treatment of HCC
  • Prevention of HCC
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Pharmacist and nursing credit provided through the cosponsorship of Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.